Is it possible that given some of the statements that Dr. Jorgensen has made regarding the quality of our research teams and the labs, coupled with all the definitive trial "results" data from the past B trial, that there could have been some compelling improvements to Brilacidin by our clinical research teams ? I'm not at my computer to look at past PR's but haven't we made adjustments ? Or did I celebrate too much last night : ) Thanks.
News 
Market Data 
Discover 
